384 filings
Page 5 of 20
8-K
u3n l2vp62
24 Aug 22
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
3nq9n3yu70vo hv638i9
11 Aug 22
Motus GI Reports Second Quarter 2022 Financial Results
4:10pm
8-K
5b4d7ts7xmvd277qc
11 Aug 22
Other Events
8:05am
8-K
y19u82g43 h2d98v
26 Jul 22
Material Modifications to Rights of Security Holders
9:00am
8-K
q2u5igdyz clcuk
30 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
a69bru3dc747
24 May 22
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System
4:10pm
DEFA14A
bz0teei
23 May 22
Additional proxy soliciting materials
4:30pm
8-K
ojqkjh
12 May 22
Motus GI Reports First Quarter 2022 Financial Results
4:10pm
8-K
wr28lkuspr9iw6m
21 Apr 22
Regulation FD Disclosure
8:05am
8-K
rpmgr9
11 Apr 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:30pm
424B5
cvxrdm4 ok
29 Mar 22
Prospectus supplement for primary offering
4:20pm
S-8
sm04ghx ceov
29 Mar 22
Registration of securities for employees
4:15pm
8-K
4n8e6 0df6vf2sch3uf
29 Mar 22
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
0e8v2omt404 gb6y
24 Feb 22
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
8:10am
8-K
a2935a
14 Feb 22
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
6:40am